About NAGASE
NAGASE is a company based in Kyoto (Japan) founded in 1832. The company has 7,480 employees as of March 31, 2024. NAGASE has completed 3 acquisitions, including Bridgestone Arena, IGENE Therapeutics and PacTech.
- Headquarter Kyoto, Japan
- Employees 7480 as on 31 Mar, 2024
- Stage Public
-
Sectors
Chemicals & Materials
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nagase & Co., Ltd.
-
Annual Revenue
$6.32 B (USD)4.98as on Mar 31, 2025
-
Net Profit
$170.78 M (USD)13.92as on Mar 31, 2025
-
EBITDA
$382.31 M (USD)20.93as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
7480
as on Mar 31, 2024
-
Investments & Acquisitions
Bridgestone Arena
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of NAGASE
NAGASE is a publicly listed company on the TSE with ticker symbol 8012 in Japan, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of NAGASE
Unlock access to complete
Unlock access to complete
Leadership Team
25 people
Vice Team
1 people
Software Development Team
1 people
Chairman Team
1 people
Unlock access to complete
Funding Insights of NAGASE
Detailed funding history for NAGASE
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NAGASE
NAGASE has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Bridgestone Arena, IGENE Therapeutics and PacTech.
Investment portfolio details for NAGASE
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Gene therapy-based drug discovery is conducted by iGene Therapeutics.
|
Locked | Locked | 2003 | Locked | |
|
Marketplace for event discovery and ticket booking is operated.
|
Locked | Locked | 1996 | Locked | |
|
Wafer bumping, packaging, and solder ball placement equipment is provided.
|
Locked | Locked | 1995 | Locked |
Complete acquisition details for NAGASE
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - NAGASE
Detailed financials for NAGASE
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nagase Comparisons
Peer comparison for NAGASE
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NAGASE
Detailed competitors of NAGASE
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nagase
Complete news archive for NAGASE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NAGASE
NAGASE was founded in 1832.
NAGASE is headquartered in Kyoto, Japan. It is registered at Kyoto, Kyoto Prefecture, Japan.
Hiroyuki Ueshima is the current CEO of NAGASE.
As of Mar 31, 2024, the latest employee count at NAGASE is 7,480.
Annual revenue of NAGASE is $6.32B as on Mar 31, 2025.
The company was founded in 1832 in Kyoto, Japan, and operates as a manufacturer of diversified chemicals. A broad array of products is supplied across industries including plastics, electronics, automotive components, active pharmaceutical ingredients, functional food materials, 3D printing substances, adhesives, sealants, anti-microbial agents, and compostable biodegradable compounds. Focus is placed on supporting industrial applications through these chemical solutions.
Yes, NAGASE is publicly traded on TSE under the ticker symbol 8012.
NAGASE has made 3 acquisitions, including Bridgestone Arena, IGENE Therapeutics, and PacTech.
The ticker symbol of NAGASE is 8012 on TSE.